Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate – The ICE randomized clinical trial
Titel:
Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate – The ICE randomized clinical trial
Auteur:
Schmidt, Marcus Nitz, Ulrike Reimer, Toralf Schmatloch, Sabine Graf, Heiko Just, Marianne Stickeler, Elmar Untch, Michael Runnebaum, Ingo Belau, Antje Huober, Jens Jackisch, Christian Hofmann, Manfred Krocker, Jutta Nekljudova, Valentina Loibl, Sibylle